Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

Tandstad, T. ; Cohn-Cedermark, G. ; Dahl, O. ; Stierner, U. ; Cavallin-Stahl, E. ; Bremnes, R.M. ; Klepp, O.

Oxford: Elsevier Ltd

Texto completo disponível

Reply to ‘The challenge to one course carboplatin in seminoma clinical stage 1’ by Dieckmann and Anheuser

Tandstad, T. ; Cohn-Cedermark, G.

England: Elsevier Ltd

Texto completo disponível

2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

Bachner, M. ; Loriot, Y. ; Gross-Goupil, M. ; Zucali, P.A. ; Horwich, A. ; Germa-Lluch, J.-R. ; Kollmannsberger, C. ; Stoiber, F. ; Fléchon, A. ; Oechsle, K. ; Gillessen, S. ; Oldenburg, J. ; Cohn-Cedermark, G. ; Daugaard, G. ; Morelli, F. ; Sella, A. ; Harland, S. ; Kerst, M. ; Gampe, J. ; Dittrich, C. ; Fizazi, K. ; De Santis, M.

Oxford: Elsevier Ltd

Texto completo disponível

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Tandstad, T. ; Ståhl, O. ; Dahl, O. ; Haugnes, H.S. ; Håkansson, U. ; Karlsdottir, Å. ; Kjellman, A. ; Langberg, C.W. ; Laurell, A. ; Oldenburg, J. ; Solberg, A. ; Söderström, K. ; Stierner, U. ; Cavallin-Ståhl, E. ; Wahlqvist, R. ; Wall, N. ; Cohn-Cedermark, G.

England: Elsevier Ltd

Texto completo disponível

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

Tandstad, T. ; Ståhl, O. ; Håkansson, U. ; Dahl, O. ; Haugnes, H.S. ; Klepp, O.H. ; Langberg, C.W. ; Laurell, A. ; Oldenburg, J. ; Solberg, A. ; Söderström, K. ; Cavallin-Ståhl, E. ; Stierner, U. ; Wahlquist, R. ; Wall, N. ; Cohn-Cedermark, G.

Oxford: Elsevier Ltd

Texto completo disponível

Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment

Weibring, K. ; Nord, C. ; Ståhl, O. ; Eberhard, J. ; Sandberg, K. ; Johansson, H. ; Arver, S. ; Giwercman, A. ; Cohn-Cedermark, G.

England: Elsevier Ltd

Texto completo disponível

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

Oldenburg, J. ; Aparicio, J. ; Beyer, J. ; Cohn-Cedermark, G. ; Cullen, M. ; Gilligan, T. ; De Giorgi, U. ; De Santis, M. ; de Wit, R. ; Fosså, S.D. ; Germà-Lluch, J.R. ; Gillessen, S. ; Haugnes, H.S. ; Honecker, F. ; Horwich, A. ; Lorch, A. ; Ondruš, D. ; Rosti, G. ; Stephenson, A.J. ; Tandstad, T.

England: Elsevier Ltd

Texto completo disponível

Intermediate prognosis in metastatic germ cell tumors (IPGCT): Outcome and prognostic stratification

Seidel, C. ; Daugaard, K.G. ; Tryakin, A. ; Necchi, A. ; Cohn Cedermark, G. ; Ståhl, O. ; Hentrich, M. ; Brito, M. ; Albany, C. ; Taza, F. ; Gerl, A. ; Oechsle, K. ; Oing, C. ; Bokemeyer, C.

England: Elsevier Ltd

Texto completo disponível

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Honecker, F. ; Aparicio, J. ; Berney, D. ; Beyer, J. ; Bokemeyer, C. ; Cathomas, R. ; Clarke, N. ; Cohn-Cedermark, G. ; Daugaard, G. ; Dieckmann, K.-P. ; Fizazi, K. ; Fosså, S. ; Germa-Lluch, J.R. ; Giannatempo, P. ; Gietema, J.A. ; Gillessen, S. ; Haugnes, H.S. ; Heidenreich, A. ; Hemminki, K. ; Huddart, R. ; Jewett, M.A.S. ; Joly, F. ; Lauritsen, J. ; Lorch, A. ; Necchi, A. ; Nicolai, N. ; Oing, C. ; Oldenburg, J. ; Ondruš, D. ; Papachristofilou, A. ; Powles, T. ; Sohaib, A. ; Ståhl, O. ; Tandstad, T. ; Toner, G. ; Horwich, A.

England: Elsevier Ltd

Texto completo disponível

A Prostate Cancer Expression Signature to Predict Survival Benefit of Primary Hormone Therapy

Li, C. ; Peng, Z. ; Skoog, L. ; Hjelm-Eriksson, M. ; Ährlund-Richter, L. ; Harmenberg, U. ; Pawitan, Y. ; Cedermark, G. Cohn ; Nistér, M. ; Nilsson, S.

Texto completo disponível